APPLICATION OF RECOMBINANT GANODERMA LUCIDUM IMMUNOMODULATORY PROTEIN (RLZ-8) IN TREATMENT OF LUNG CANCER, LARYNGEAL CANCER, AND BRAIN GLIOMA

摘要

Disclosed in the present invention is an application of recombinant ganoderma lucidum immunomodulatory protein (rLZ-8) in the treatment of lung cancer, laryngeal cancer, and brain glioma. To research the in-vivo anti-tumour effect of rLZ-8, the present invention respectively established a lung cancer mouse model by means of a tail vein injection method and established a laryngeal cancer and a brain glioma nude mouse model by means of a subcutaneous tumour implantation method; the treatment results demonstrate that rLZ-8 has an anti-tumour effect with regard to lung cancer, laryngeal cancer, and brain glioma.